138 related articles for article (PubMed ID: 18399058)
1. Mammographic density--a risk factor for breast cancer.
Fait T; Zizka Z
Prague Med Rep; 2007; 108(3):205-14. PubMed ID: 18399058
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.
Kavanagh AM; Cawson J; Byrnes GB; Giles GG; Marr G; Tong B; Gertig DM; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1060-4. PubMed ID: 15894653
[TBL] [Abstract][Full Text] [Related]
3. Mammographic density and estrogen receptor status of breast cancer.
Ziv E; Tice J; Smith-Bindman R; Shepherd J; Cummings S; Kerlikowske K
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2090-5. PubMed ID: 15598766
[TBL] [Abstract][Full Text] [Related]
4. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
[TBL] [Abstract][Full Text] [Related]
5. [Menopausal hormonal therapies: impact on mammographic breast density].
Boutet G; Boisserie-Lacroix M; Trillaud H
J Radiol; 2004 Oct; 85(10 Pt 1):1673-86. PubMed ID: 15669560
[TBL] [Abstract][Full Text] [Related]
6. Menopausal hormone therapies: their effect on mammographic density and breast cancer risk.
Santen R
Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():12-6. PubMed ID: 16112950
[TBL] [Abstract][Full Text] [Related]
7. Exogenous and endogenous hormones, mammographic density and breast cancer risk: can mammographic density be considered an intermediate marker of risk?
Becker S; Kaaks R
Recent Results Cancer Res; 2009; 181():135-57. PubMed ID: 19213565
[TBL] [Abstract][Full Text] [Related]
8. Mammographic breast density changes after 1 year of tibolone use.
Kutlu T; Fiçicioğlu C; Başaran T; Başaran E; Topaloğlu T
Maturitas; 2004 Jun; 48(2):133-6. PubMed ID: 15172087
[TBL] [Abstract][Full Text] [Related]
9. [Mammographic density as indicator of breast cancer risk].
Ursin G
Tidsskr Nor Laegeforen; 2003 Dec; 123(23):3373-6. PubMed ID: 14713971
[TBL] [Abstract][Full Text] [Related]
10. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
[TBL] [Abstract][Full Text] [Related]
11. Mammographic density: a hormonally responsive risk factor for breast cancer.
Boyd NF; Martin LJ; Yaffe MJ; Minkin S
J Br Menopause Soc; 2006 Dec; 12(4):186-93. PubMed ID: 17178021
[TBL] [Abstract][Full Text] [Related]
12. Postmenopausal hormone therapy and mammographic breast density.
Marchesoni D; Driul L; Ianni A; Fabiani G; Della Martina M; Zuiani C; Bazzocchi M
Maturitas; 2006 Jan; 53(1):59-64. PubMed ID: 15939560
[TBL] [Abstract][Full Text] [Related]
13. Are breast density and bone mineral density independent risk factors for breast cancer?
Kerlikowske K; Shepherd J; Creasman J; Tice JA; Ziv E; Cummings SR
J Natl Cancer Inst; 2005 Mar; 97(5):368-74. PubMed ID: 15741573
[TBL] [Abstract][Full Text] [Related]
14. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
Tamimi RM; Byrne C; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
[TBL] [Abstract][Full Text] [Related]
15. Different types of postmenopausal hormone therapy and mammographic density in Norwegian women.
Bremnes Y; Ursin G; Bjurstam N; Lund E; Gram IT
Int J Cancer; 2007 Feb; 120(4):880-4. PubMed ID: 17131324
[TBL] [Abstract][Full Text] [Related]
16. Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women.
Bremnes Y; Ursin G; Bjurstam N; Rinaldi S; Kaaks R; Gram IT
Int J Cancer; 2007 Dec; 121(11):2506-11. PubMed ID: 17657735
[TBL] [Abstract][Full Text] [Related]
17. [Mammographic breast density and breast cancer risk during HRT].
Bock K; Hadji P; Duda VF; Jackisch C; Wagner U
Zentralbl Gynakol; 2005 Aug; 127(4):217-21. PubMed ID: 16037902
[TBL] [Abstract][Full Text] [Related]
18. Is mammographic density, as currently measured, a robust surrogate marker for breast cancer?
Yaffe M; Hendrix S; Pike M; Santen R; Eden J; Genazzani A
Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():17-21. PubMed ID: 16112951
[TBL] [Abstract][Full Text] [Related]
19. Breast response to menopausal hormone therapy--aspects on proliferation, apoptosis and mammographic density.
Conner P
Ann Med; 2007; 39(1):28-41. PubMed ID: 17364449
[TBL] [Abstract][Full Text] [Related]
20. [Hormones and mammographic breast density].
Boisserie-Lacroix M; Lebiez-Michel N; Cavagni P; Bentolila J; Laumonier H; Bouzgarrou M; Trillaud H
J Radiol; 2008 Sep; 89(9 Pt 2):1196-203. PubMed ID: 18772804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
